Programmed death ligand-1 (PD-L1) is one of these immune checkpoints, which can inhibit the function of immune cells by binding to programmed death-1 (PD-1) expressed on it, thereby allowing tumor cells to escape [9]. Here, CD274 is linked to neoplasm.